Cargando…

Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: a pilot study

INTRODUCTION: Rheumatic heart disease (RHD) continues to cause gross distortions of the heart and the associated complications of heart failure and thromboembolic phenomena in this age of numerous high-efficacy drugs and therapeutic interventions. Due to the lack of contemporary local data, there is...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondo, Charles, Musoke, Charles, Kayima, James, Freers, Jurgen, Zhang, Wanzhu, Okello, Emmy, Kakande, Barbara, Nyakoojo, Wilson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734881/
https://www.ncbi.nlm.nih.gov/pubmed/23612950
http://dx.doi.org/10.5830/CVJA-2012-076
_version_ 1782279600249765888
author Mondo, Charles
Musoke, Charles
Kayima, James
Freers, Jurgen
Zhang, Wanzhu
Okello, Emmy
Kakande, Barbara
Nyakoojo, Wilson
author_facet Mondo, Charles
Musoke, Charles
Kayima, James
Freers, Jurgen
Zhang, Wanzhu
Okello, Emmy
Kakande, Barbara
Nyakoojo, Wilson
author_sort Mondo, Charles
collection PubMed
description INTRODUCTION: Rheumatic heart disease (RHD) continues to cause gross distortions of the heart and the associated complications of heart failure and thromboembolic phenomena in this age of numerous high-efficacy drugs and therapeutic interventions. Due to the lack of contemporary local data, there is no national strategy for the control and eradication of the disease in Uganda. This study aimed to describe the presenting clinical features of newly diagnosed patients with RHD, with particular reference to the frequency of serious complications (atrial fibrillation, systemic embolism, heart failure and pulmonary hypertension) in the study group. METHODS: One hundred and thirty consecutive patients who satisfied the inclusion criteria were recruited over a period of eight months from June 2011 to January 2012 at the Mulago Hospital, Uganda. Data on demographic characteristics, disease severity and presence of complications were collected by means of a standardised questionnaire. RESULTS: Seventy-one per cent of the patients were female with a median age of 33 years. The peak age of the study group was 20 to 39 years, with the commonest presenting symptoms being palpitations, fatigue, chest pain and dyspnoea. The majority of the patients presented with moderate-to-severe valvular disease. Pure mitral regurgitation was the commonest valvular disease (40.2%), followed by mitral regurgitation plus aortic regurgitation (29%). Mitral regurgitation plus aortic regurgitation plus mitral stenosis was found in 11% of patients. There was only one case involving the tricuspid valve. The pulmonary valves were not affected in all patients; 45.9% of patients presented in severe heart failure in NYHA class III/IV, 53.3% had pulmonary hypertension, 13.9% had atrial fibrillation and 8.2% had infective endocarditis. All patients presented with dilated atria (> 49 mm). CONCLUSION: A significant proportion of RHD patients present to hospital with severe disease associated with severe complications of advanced heart failure, pulmonary hypertension, infective endocarditis and atrial fibrillation. There is a need to improve awareness of the disease among the population, and clinical suspicion in primary health workers, so that early referral to specialist management can be done before severe damage to the heart ensues.
format Online
Article
Text
id pubmed-3734881
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Clinics Cardive Publishing
record_format MEDLINE/PubMed
spelling pubmed-37348812013-08-07 Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: a pilot study Mondo, Charles Musoke, Charles Kayima, James Freers, Jurgen Zhang, Wanzhu Okello, Emmy Kakande, Barbara Nyakoojo, Wilson Cardiovasc J Afr Cardiovascular Topics INTRODUCTION: Rheumatic heart disease (RHD) continues to cause gross distortions of the heart and the associated complications of heart failure and thromboembolic phenomena in this age of numerous high-efficacy drugs and therapeutic interventions. Due to the lack of contemporary local data, there is no national strategy for the control and eradication of the disease in Uganda. This study aimed to describe the presenting clinical features of newly diagnosed patients with RHD, with particular reference to the frequency of serious complications (atrial fibrillation, systemic embolism, heart failure and pulmonary hypertension) in the study group. METHODS: One hundred and thirty consecutive patients who satisfied the inclusion criteria were recruited over a period of eight months from June 2011 to January 2012 at the Mulago Hospital, Uganda. Data on demographic characteristics, disease severity and presence of complications were collected by means of a standardised questionnaire. RESULTS: Seventy-one per cent of the patients were female with a median age of 33 years. The peak age of the study group was 20 to 39 years, with the commonest presenting symptoms being palpitations, fatigue, chest pain and dyspnoea. The majority of the patients presented with moderate-to-severe valvular disease. Pure mitral regurgitation was the commonest valvular disease (40.2%), followed by mitral regurgitation plus aortic regurgitation (29%). Mitral regurgitation plus aortic regurgitation plus mitral stenosis was found in 11% of patients. There was only one case involving the tricuspid valve. The pulmonary valves were not affected in all patients; 45.9% of patients presented in severe heart failure in NYHA class III/IV, 53.3% had pulmonary hypertension, 13.9% had atrial fibrillation and 8.2% had infective endocarditis. All patients presented with dilated atria (> 49 mm). CONCLUSION: A significant proportion of RHD patients present to hospital with severe disease associated with severe complications of advanced heart failure, pulmonary hypertension, infective endocarditis and atrial fibrillation. There is a need to improve awareness of the disease among the population, and clinical suspicion in primary health workers, so that early referral to specialist management can be done before severe damage to the heart ensues. Clinics Cardive Publishing 2013-03 /pmc/articles/PMC3734881/ /pubmed/23612950 http://dx.doi.org/10.5830/CVJA-2012-076 Text en Copyright © 2010 Clinics Cardive Publishing http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cardiovascular Topics
Mondo, Charles
Musoke, Charles
Kayima, James
Freers, Jurgen
Zhang, Wanzhu
Okello, Emmy
Kakande, Barbara
Nyakoojo, Wilson
Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: a pilot study
title Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: a pilot study
title_full Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: a pilot study
title_fullStr Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: a pilot study
title_full_unstemmed Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: a pilot study
title_short Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: a pilot study
title_sort presenting features of newly diagnosed rheumatic heart disease patients in mulago hospital: a pilot study
topic Cardiovascular Topics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734881/
https://www.ncbi.nlm.nih.gov/pubmed/23612950
http://dx.doi.org/10.5830/CVJA-2012-076
work_keys_str_mv AT mondocharles presentingfeaturesofnewlydiagnosedrheumaticheartdiseasepatientsinmulagohospitalapilotstudy
AT musokecharles presentingfeaturesofnewlydiagnosedrheumaticheartdiseasepatientsinmulagohospitalapilotstudy
AT kayimajames presentingfeaturesofnewlydiagnosedrheumaticheartdiseasepatientsinmulagohospitalapilotstudy
AT freersjurgen presentingfeaturesofnewlydiagnosedrheumaticheartdiseasepatientsinmulagohospitalapilotstudy
AT zhangwanzhu presentingfeaturesofnewlydiagnosedrheumaticheartdiseasepatientsinmulagohospitalapilotstudy
AT okelloemmy presentingfeaturesofnewlydiagnosedrheumaticheartdiseasepatientsinmulagohospitalapilotstudy
AT kakandebarbara presentingfeaturesofnewlydiagnosedrheumaticheartdiseasepatientsinmulagohospitalapilotstudy
AT nyakoojowilson presentingfeaturesofnewlydiagnosedrheumaticheartdiseasepatientsinmulagohospitalapilotstudy